Berger Mark Stanley 4
4 · Actinium Pharmaceuticals, Inc. · Filed Mar 19, 2018
Insider Transaction Report
Form 4
Berger Mark Stanley
Chief Medical Officer
Transactions
- Other
Common Stock
2018-03-06$0.50/sh+14,000$7,000→ 19,000 total - Other
Series B Warrants
2018-03-06$0.50/sh+10,500$5,250→ 10,500 totalExercise: $0.70From: 2018-03-06Exp: 2020-09-06→ Common Stock (10,500 underlying) - Other
Series A Warrants
2018-03-06$0.50/sh+3,500$1,750→ 3,500 totalExercise: $0.60From: 2018-03-06Exp: 2019-03-06→ Common Stock (3,500 underlying)